| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 56 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.22M | $9.79M | - | |
| CFO | 235.0K | $1.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2021 | Melian Agustin83 | Chief Medical Officer | Sell | 3,750 | $25.97 | $97,393.50 | -0.7% | -16.2% | -68.2% | |
| Mar 16, 2021 | Leen Ann M.83 | Chief Scientific Officer | Sell | 3,025 | $30.00 | $90,750.91 | -0.1% | -20.9% | -72.0% | |
| Mar 11, 2021 | Wilson John Robert53 | Director | Sell | 200,002 | $31.34 | $6,268,101.33 | -0.3% | -23.4% | -74.6% | |
| Mar 5, 2021 | Brenner Malcolm | Director | Sell | 97,689 | $33.50 | $3,272,798.11 | -1.3% | - | - | |
| Mar 3, 2021 | Brenner Malcolm | Director | Sell | 52,267 | $38.28 | $2,000,565.35 | -0.7% | - | - | |
| Mar 3, 2021 | Vera Juan | Director | Sell | 63,836 | $38.41 | $2,451,759.67 | -0.3% | - | - | |
| Mar 1, 2021 | Van Beek Jeroen B85 | Chief Commercial Officer | Sell | 5,932 | $38.78 | $230,033.50 | -0.6% | - | - | |
| Mar 1, 2021 | Miller Edward82 | General Counsel | Sell | 6,000 | $38.78 | $232,699.40 | -1.5% | - | - | |
| Mar 1, 2021 | Leen Ann M.83 | Chief Scientific Officer | Sell | 9,518 | $38.70 | $368,329.21 | -0.2% | - | - | |
| Feb 23, 2021 | Brenner Malcolm | Director | Sell | 31,902 | $41.45 | $1,322,217.19 | -0.4% | - | - |